Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Pancreatic intraglandular metastasis predicts poorer outcome in postoperative patients with pancreatic ductal carcinoma.

Oguro S, Shimada K, Ino Y, Esaki M, Nara S, Kishi Y, Kosuge T, Kanai Y, Hiraoka N.

Am J Surg Pathol. 2013 Jul;37(7):1030-8. doi: 10.1097/PAS.0b013e3182834d22.

PMID:
23648465
2.

Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.

Helm J, Centeno BA, Coppola D, Melis M, Lloyd M, Park JY, Chen DT, Malafa MP.

Cancer. 2009 Sep 15;115(18):4080-9. doi: 10.1002/cncr.24503.

3.

[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].

Ridwelski K, Meyer F, Schmidt U, Lippert H.

Zentralbl Chir. 2005 Aug;130(4):353-61. German.

PMID:
16103961
4.

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Maire F, Hammel P, Terris B, Paye F, Scoazec JY, Cellier C, Barthet M, O'Toole D, Rufat P, Partensky C, Cuillerier E, Lévy P, Belghiti J, Ruszniewski P.

Gut. 2002 Nov;51(5):717-22.

5.

Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.

Nanashima A, Tobinaga S, Abo T, Hatano K, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T, Nagayasu T.

Hepatogastroenterology. 2012 May;59(115):911-5. doi: 10.5754/hge10038.

PMID:
22469741
6.

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.

Pancreas. 2008 Jan;36(1):50-5. doi: 10.1097/MPA.0b013e31812575df.

PMID:
18192881
7.

Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer?

Tani M, Kawai M, Terasawa H, Ina S, Hirono S, Uchiyama K, Yamaue H.

J Surg Oncol. 2006 May 1;93(6):485-90.

PMID:
16615151
8.

Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.

Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K, Araki H, Matsui Y, Imamura A, Kwon AH, Kamiyama Y.

Pancreas. 2003 Apr;26(3):243-9.

PMID:
12657950
9.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

10.

Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N.

Ann Surg Oncol. 2007 Nov;14(11):3174-80. Epub 2007 Aug 12.

PMID:
17694416
11.

Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.

Kang CM, Kim DH, Choi GH, Kim KS, Choi JS, Lee WJ.

J Gastrointest Surg. 2009 May;13(5):907-14. doi: 10.1007/s11605-009-0823-9. Epub 2009 Feb 18.

PMID:
19224295
12.

Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?

Miyazaki M, Yoshitomi H, Shimizu H, Ohtsuka M, Yoshidome H, Furukawa K, Takayasiki T, Kuboki S, Okamura D, Suzuki D, Nakajima M.

Surgery. 2014 Jan;155(1):58-66. doi: 10.1016/j.surg.2013.06.050. Epub 2013 Nov 12.

PMID:
24238124
13.

No-touch pancreatectomy for invasive ductal carcinoma of the pancreas.

Hirota M, Ogawa M.

JOP. 2014 May 27;15(3):243-9. doi: 10.6092/1590-8577/2502.

14.

Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.

Liu C, Yang Z, Li D, Liu Z, Miao X, Yang L, Zou Q, Yuan Y.

Cancer Biomark. 2015;15(6):735-43. doi: 10.3233/CBM-150515.

PMID:
26406402
15.

Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma.

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Yuasa Y, Kondo N, Ohge H, Sueda T.

J Am Coll Surg. 2010 Aug;211(2):196-204. doi: 10.1016/j.jamcollsurg.2010.03.037. Epub 2010 Jun 8.

PMID:
20670857
16.

Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.

Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, Nanno Y, Yamashita A, Mizumoto T, Ueda Y, Kido M, Ajiki T, Fukumoto T, Ku Y.

Pancreatology. 2016 Jul-Aug;16(4):615-20. doi: 10.1016/j.pan.2016.05.003. Epub 2016 May 14.

PMID:
27237099
17.

Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.

Park JB, Kim YH, Kim J, Chang HM, Kim TW, Kim SC, Kim PN, Han DJ.

J Vasc Interv Radiol. 2012 May;23(5):635-41. doi: 10.1016/j.jvir.2012.01.080.

PMID:
22525021
18.

Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S.

J Am Coll Surg. 2004 May;198(5):722-31.

PMID:
15110805
19.

Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.

Waraya M, Yamashita K, Katagiri H, Ishii K, Takahashi Y, Furuta K, Watanabe M.

Ann Surg Oncol. 2009 May;16(5):1231-40. doi: 10.1245/s10434-009-0415-7. Epub 2009 Mar 5.

PMID:
19263172
20.

Is celiac axis resection justified for T4 pancreatic body cancer?

Yamamoto Y, Sakamoto Y, Ban D, Shimada K, Esaki M, Nara S, Kosuge T.

Surgery. 2012 Jan;151(1):61-9. doi: 10.1016/j.surg.2011.06.030. Epub 2011 Nov 14.

PMID:
22088810

Supplemental Content

Support Center